pyridostigmine bromide has been researched along with Constriction, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, FT; Debenham, P; Parida, A; Solanki, GA | 1 |
| Huang, N; Liu, JJ; Lu, Y; Yang, Y; Yang, YH; Yu, XJ; Zang, WJ; Zhao, M | 1 |
1 review(s) available for pyridostigmine bromide and Constriction, Pathological
| Article | Year |
|---|---|
Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update.
Topics: Achondroplasia; Anesthetics; Azathioprine; Child; Constriction, Pathologic; COVID-19; Female; Humans; Myasthenia Gravis; Nucleotides; Pandemics; Pyridostigmine Bromide; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Cholinergic; Spinal Cord Compression | 2022 |
1 other study(ies) available for pyridostigmine bromide and Constriction, Pathological
| Article | Year |
|---|---|
Improving vagal activity ameliorates cardiac fibrosis induced by angiotensin II: in vivo and in vitro.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Collagen; Constriction, Pathologic; Drug Evaluation, Preclinical; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Heart Diseases; Male; Pyridostigmine Bromide; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Vagus Nerve | 2015 |